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Histological evolution of pleuroparenchymal fibroelastosis
Aims: To investigate the histological evolution in the
development of pleuroparenchymal fibroelastosis
(PPFE).
Methods and results: We examined four patients
who had undergone surgical lung biopsy twice, or
who had undergone surgical lung biopsy and had
been autopsied, and in whom the histological
diagnosis of the first biopsy was not PPFE, but the
diagnosis of the second biopsy or of the autopsy
was PPFE. The histological patterns of the first
biopsy were cellular and fibrotic interstitial pneumo-
nia, cellular interstitial pneumonia (CIP) with orga-
nizing pneumonia, CIP with granulomas and acute
lung injury in cases 1, 2, 3, and 4, respectively.
Septal elastosis was already present in the non-spe-
cific interstitial pneumonia-like histology of case 1,
but a few additional years were necessary to reach
consolidated subpleural fibroelastosis. In case 3, sub-
pleural fibroelastosis was already present in the first
biopsy, but only to a small extent. Twelve years
later, it was replaced by a long band of fibroelasto-
sis. The septal inflammation and fibrosis and air-
space organization observed in the first biopsies
were replaced by less cellular subpleural fibroelasto-
sis within 3–12 years.
Conclusions: Interstitial inflammation or acute lung
injury may be an initial step in the development of
PPFE.
Keywords: acute lung injury, cellular interstitial pneumonia, idiopathic interstitial pneumonia, idiopathic
pulmonary fibrosis, organizing pneumonia, pleuroparenchymal fibroelastosis, pulmonary upper lobe fibrosis
Introduction
Pleuroparenchymal fibroelastosis (PPFE) is a unique
clinicopathological entity that was first described by
Frankel et al.1 Idiopathic PPFE is now listed as one of
the rare idiopathic interstitial pneumonias (IIPs) in the
updated classification of IIPs.2 The concept of PPFE,
regarding both clinical features and histopathology,
overlaps with that of idiopathic pulmonary upper lobe
fibrosis (PULF), which was described initially by Ami-
tani et al.3 According to that description, idiopathic
PULF has been considered to progress slowly, with
10–20 years of presentation. Recently, however, it has
been disclosed that PPFE or PULF sometimes progresses
rapidly, with a poor prognosis.4,5 Its pathogenesis
appears to be heterogeneous.6
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Regarding the evolution of idiopathic pulmonary
fibrosis (IPF), it was once widely accepted that end-
stage fibrosis is reached via an inflammatory process
that starts at the early stage in the lung parenchyma.
However, it is now believed that the inflammatory
stage is not absolutely necessary for the development
of fibrosis; that is, the fibrotic process that follows epi-
thelial injuries could start in the initial stage of the
disease, without inflammation.7 If this is so, what
process intervenes in the progression to the estab-
lished fibroelastosis in PPFE?
In 2013, Ofek et al.8 published an article that
described PPFE as a pathological phenotype of restric-
tive allograft syndrome following lung transplanta-
tion. In that report, the authors showed that PPFE
was often associated with diffuse alveolar damage
(DAD), and their findings suggested a temporal
sequence of DAD followed by the development of
PPFE. We hypothesized that not only transplantation-
associated PPFE, but also other forms of PPFE, idio-
pathic or secondary, may have an inflammatory or
acute lung injury (ALI) process prior to the develop-
ment of PPFE. In this article, we present four patients
with PPFE who showed features of cellular and fibro-
tic interstitial pneumonia, cellular interstitial pneu-
monia (CIP) and an ALI pattern in the first biopsy,
and subpleural fibroelastosis in the second biopsy or
autopsy. Herein, we discuss the evolution of PPFE
regarding the relationships between clinical charac-
teristics and imaging and histological findings.
Materials and methods
We reviewed the medical files of all patients admitted
to the Departments of Respiratory Medicine at the Fu-
kuoka University Hospital, National Hospital Organi-
zation Fukuoka Higashi Medical Centre and
Hamanomachi Hospital from 2006 to 2013, and
selected four patients who had undergone surgical
lung biopsy twice, or who had undergone surgical
lung biopsy and had been autopsied, and in whom
the main histological feature of the first biopsy was
not PPFE, but the diagnosis of the second biopsy or
autopsy was PPFE. Histological findings were
reviewed in specimens stained with haematoxylin
and eosin and with elastica van Gieson (EVG), to
determine the histological differences between first
biopsy and second biopsy or autopsy. Clinical data,
including serum levels of Krebs von den Lungen-6
(KL-6) and imaging findings, were also reviewed.
KL-6, a high molecular mass mucin-like glycoprotein,
was originally identified by Kohno et al.,9 and has
been reported to be a sensitive marker for interstitial
lung diseases, such as IPF10 and non-specific intersti-
tial pneumonia (NSIP).11 Serum levels of KL-6 in
PPFE patients are reported to be around the normal
upper limit, and tend to be elevated during the course
of the disease. Alveolar epithelial cells are likely to be
involved in the fibrotic process of the disease, as in
other fibrosing or cellular IIPs.5,6
The institutional review board of Fukuoka Univer-
sity Hospital approved this retrospective study (#14-
5-16).
Results
The clinical characteristics and laboratory data of the
four patients are shown in Table 1. Three of the four
patients never smoked, and all patients were lean,
with a body mass index of 16.9  0.8 kg/m2
(mean  standard error). The serum levels of KL-6
were 510  104 U/ml, which is around the normal
upper limit.
C A S E 1
A 69-year-old man with chest pain visited our hospi-
tal. Chest computed tomography (CT) revealed ill-
defined nodular opacities attached to the pleura in
both the upper and lower lung fields. Six months
later, one of the lesions in the right S5 was biopsied
by video-assisted thoracoscopic surgery (VATS).
Although alveolar architectures were mostly pre-
served histologically, alveolar septa were diffusely
thickened, with fibrosis and a mild degree of mononu-
clear cell infiltration (Figure 1A,B). The patient was
then observed in the outpatient clinic. However, his
general condition became gradually worse, with
increasing dyspnoea. Multiple nodular opacities with
fibrosis on chest CT were also advanced.
Three years and 7 months after the biopsy, the
patient was admitted to our hospital. Corticosteroids
and cyclophosphamide were administered, but with-
out any beneficial effect. The patient died of rapidly
progressive respiratory failure at 41 hospital days,
and was autopsied. Autopsy revealed DAD, which
seemed to be the direct cause of death. Just beneath
the pleura thickened with collagen, there was a
band-like gathering of elastic fibres. The border
between the elastosis and the normal-appearing lung
parenchyma was sharply demarcated (Figure 1C).
These features were consistent with those of PPFE.
PPFE features were observed in all lobes of both
lungs. We reviewed the biopsy specimen, and added
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another specimen stained with EVG, which demon-
strated that alveolar septal elastosis was already pres-
ent (Figure 1D), albeit without band-like consolidated
elastosis along the visceral pleura, which is a histo-
logical prototype of PPFE, as observed in the autopsy.
C A S E 2
A 56-year-old man presenting with cough and mild
fever for 2 months underwent right lung biopsies
(right S3, S6, and S9) by VATS. Chest CT showed
small nodular opacities attached to the pleura in the
bilateral apex, and subpleural ground-glass or
reticular opacities mainly in the bilateral lower lobes
(Figure 2A). The patient had worked as a welder
for >25 years, including stainless steel welding
for 19 years. He had smoked 20 cigarettes a day for
37 years.
A biopsy specimen taken from S3 showed that
alveolar septa were uniformly thickened, with mono-
nuclear cell infiltration; however, the lung architec-
ture was preserved. S6 showed similar microscopic
findings. However, in another biopsy specimen taken
from S9, alveolar septa were more prominently infil-
trated by mononuclear cells. In addition, septal fibro-
sis and airspace organization were present
(Figure 3A,B). The patient was treated with predniso-
lone and cyclosporine, without a favourable effect.
Three years and 5 months after the biopsy, chest CT
showed nodular, reticular and linear opacities with
bullae distributed mainly in the subpleural areas of
bilateral lungs (Figure 2B). The patient’s physical
condition worsened gradually to severe respiratory
failure.
Four years and 2 months after the biopsy, the
patient received a left lung transplant from a brain-
Table 1. Clinical characteristics and laboratory data
Case 1 Case 2 Case 3 Case 4
Age at first onset (years) 69 56 49 32
Gender Male Male Female Female
Age at first surgical lung
biopsy (years)
69 56 49 32
Age at second surgical lung
biopsy (years)
– – 61 –
Age at autopsy (years) 73 62 35
Smoking status (pack-years) Never-smoker Smoker (40) Never-smoker Never-smoker
History of pneumothorax No No No Yes
Past history NP NP NP IPAH
Family history of interstitial
pneumonia
No No No No
Occupational history Medical
technologist
Welder for >25
years
Manager at a
sushi bar
No occupational
history
Administration of steroids Yes Yes No Yes
Body mass index (kg/m2) 15.6 18.9 15.6 17.5
First symptoms Chest pain Cough Chest pain Exercise dyspnoea
Crackles Audible Audible Not audible Not audible
Autoantibodies No No No No
KL-6 (U/ml) 506 793 295 446
IPAH, Post-lung-transplanted state owing to idiopathic pulmonary arterial hypertension; KL-6, Krebs von den Lungen-6;
NP, nothing particular.
© 2014 The Authors. Histopathology published by John Wiley & Sons Ltd, Histopathology, 66, 545–554.
Histological evolution of PPFE 547
dead donor. A histological specimen taken from the
superior segment of the left upper lobe showed less
cellular fibrosis located in the subpleural area, partly
extending inside the lung parenchyma (Figure 3C).
EVG staining revealed that the fibrosis was coincident
with the aggregation of elastic fibres, together with
alveoli filled with mature collagen. Visceral pleurae
were locally thickened with collagen (Figure 3D).
Other specimens taken from both the left upper and
lower lobes showed similar findings. These histologi-
cal features were compatible with those of PPFE.
The patient’s forced expiratory volume in 1 s
transiently recovered from 1160 to 1910 ml after the
lung transplantation. However, bilateral diffuse
ground-glass opacities appeared gradually, and the
fibrotic shrinkage of his right lung progressed, with
deterioration in his general condition. Two years and
7 months after lung transplantation, he died of respira-
tory failure and was autopsied. The autopsy confirmed
the histological diagnosis of PPFE in the right lung. In
addition, diffuse alveolar proteinosis was found. EVG
staining was additionally performed for the biopsy
specimens, but significant elastosis was not found.
C A S E 3
A 56-year-old woman visited our hospital complain-
ing of left chest pain. Chest CT showed irregular pleu-
ral thickening or parenchymal nodular opacities
attached to the pleura in the bilateral apex. During
the subsequent 5-year follow-up without any treat-
ment, nodular opacities gradually expanded, and her
body weight decreased by 7 kg over a period of
10 years.
The patient underwent VATS biopsies of the
superior and lingular segments of the upper lobe and
A B
C D
Figure 1. A, A biopsy specimen from right S5 taken from a patient aged 69 years. Alveolar septa were diffusely thickened, with preservation
of lung structure [haematoxylin and eosin (H&E)]. B, Alveolar septa were widened with septal fibrosis and a mild degree of inflammatory
infiltration (H&E). C, An autopsy specimen taken from the right middle lobe, showing a fibroelastotic band just beneath the fibrously thick-
ened pleura [elastica van Gieson (EVG)]. D, EVG staining of right S5 at biopsy. Lung parenchyma was rich in elastic fibres, with localized
aggregates of elastic fibres and alveolar septal elastosis.
© 2014 The Authors. Histopathology published by John Wiley & Sons Ltd, Histopathology, 66, 545–554.
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AB
Figure 2. A, Chest computed tomography (CT) scan taken at the age of 56 years, just before the biopsy. B, Chest CT scan taken at the age
of 59 years, 3 years and 5 months after the biopsy.
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lower lobes of the left lung at the age of 61 years. In
the biopsied specimen of the superior segment of the
upper lobe, a band-like aggregate of elastic fibres was
observed just beneath the pleura, with a sharp
demarcation with less-involved lung parenchyma
(Figure 4A) and with intra-alveolar collagenous fibro-
sis around the elastosis. These features were identical
to those of PPFE. In the histological specimens taken
from the lingular segment and the lower lobe, subple-
ural elastosis was minimal, with micro-honeycombing
associated with the intervening deposition of collagen,
consistent with the pattern of usual interstitial pneu-
monia (UIP) rather than PPFE.
The patient’s past history revealed that she had
undergone VATS biopsy at the age of 49 years in
another hospital. Those biopsy specimens and their
paraffin blocks were obtained, and additional histo-
logical specimens stained with EVG were prepared to
compare the findings of the two biopsies. Biopsied
specimens of right S2 showed CIP associated with a
localized subpleural band of connective tissue (Fig-
ure 4B). Small granulomas with giant cells were
sparsely scattered at the border of the connective tis-
sue band (Figure 4C) and in the alveolar septa infil-
trated by mononuclear cells. The histological
findings of S4 were similar to those of S2, although
they were less prominent in cellularity and without
subpleural connective tissue bands. Although hyper-
sensitivity pneumonitis was suspected, causative
antigens were not identified. The fibrotic band was
A B
C D
Figure 3. A, A biopsy specimen from right S9 taken from a patient aged 56 years. Alveolar septa were densely infiltrated by mononuclear
cells and widened [haematoxylin and eosin (H&E)]. B, Septal fibrosis and airspace organization (H&E). C, A histological specimen taken from
the superior segment of the left upper lobe resected for lung transplantation at the age of 60 years (H&E). Lung parenchyma was less cellu-
lar than it was at the first biopsy. D, elastica van Gieson staining of the sample depicted in (C), showing subpleural fibroelastosis.
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shown to be fibroelastosis by EVG staining (Fig-
ure 4D).
C A S E 4
A 30-year-old woman with idiopathic pulmonary arte-
rial hypertension underwent living-donor lung trans-
plantation, receiving a right lower lobe from her
younger sister and a left lower lobe from her mother.
Twenty-one months after the lung transplantation, the
transplanted right lung was surgically biopsied because
of progressive dyspnoea and the presence of ground-
glass opacities in the upper lung field and interlobular
septal thickening with peribronchiolar consolidation in
the lower lung field of the right lung on chest CT. Open
lung biopsy was performed from the lower parts of the
transplanted lung. The biopsy specimen showed mas-
sive fibrosis and alveoli with septal thickening (Fig-
ure 5A). Organizing connective tissues almost
obliterated peripheral airways, intermingled with atyp-
ical epithelial cells with an eosinophilic cytoplasm (Fig-
ure 5B). These features were consistent with an ALI
pattern. In another area, intra-alveolar organizing con-
nective polyps were observed, with CIP (Figure 5C).
In spite of the high doses of corticosteroids adminis-
tered, the patient’s general condition worsened gradu-
ally, with increased bilateral interstitial opacities. She
died 52 months after lung transplantation. At
autopsy, both lungs showed a PPFE pattern (Fig-
ure 5D). The autopsy findings have been reported
elsewhere.12 Additional EVG staining for the biopsy
specimens failed to reveal significant elastosis.
A B
C D
Figure 4. A, A biopsy specimen from the superior segment of the left upper lobe taken from a patient aged 61 years, showing a typical fea-
ture of pleuroparenchymal fibroelastosis [elastica van Gieson (EVG)]. B, A biopsy specimen from right S2 taken at the age of 49 years, show-
ing cellular interstitial pneumonia with localized areas of subpleural fibrosis [haematoxylin and eosin (H&E)]. C, Higher magnification of (B)
(indicated by a black arrow), showing a granuloma with giant cells adjacent to the subpleural fibrosis (H&E). D, EVG staining of the sample
shown in (B), revealing subpleural fibrosis consisting of fibroelastosis.
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Discussion
In this study, we investigated four patients with PPFE
confirmed by second biopsy or autopsy; however, the
histological features of the first biopsies were consid-
erably different from those of the final biopsies or
autopsies.
In case 1, the interval between the biopsy and
autopsy was 3 years and 7 months. As the PPFE pat-
tern was observed in all lobes of bilateral lungs at
autopsy, it is probable that the NSIP-like pattern
observed in the biopsy evolved to subpleural bands of
fibroelastosis; that is, alveoli with septal elastosis were
gradually compressed, consolidated, and shifted to
subpleural areas. Fibroelastosis was already present
in the first biopsy, but another few years were
required for completion of subpleural fibroelastosis,
which is a histological hallmark of PPFE.
In case 2, clinical observations revealed the gradual,
but seamless, exacerbation of the disease without
imaging improvement, and a PPFE pattern was
observed in all specimens taken from the resected left
lung. Therefore, it is unlikely that PPFE occurred inde-
pendently of the histological pattern, i.e. cellular and
fibrotic interstitial pneumonia with organizing pneu-
monia (OP), observed in the biopsy. Prednisolone and
cyclosporine seemed to cure the interstitial inflamma-
tion, but were unable to prevent disease progression.
Subpleural fibroelastosis was identified in both the
first and second biopsies in case 3, but it was more
widely distributed in the second biopsy. CIP with
granulomas in the first biopsy was not present in the
A B
C D
Figure 5. A, A biopsy specimen from the lower part of the transplanted right lung, showing fibrosis and cellular interstitial pneumonia [hae-
matoxylin and eosin (H&E)]. B, Higher-magnification view of the biopsied sample, showing an organizing diffuse alveolar damage pattern
(H&E). C, Another area of the biopsied lung at higher magnification, showing an organizing pneumonia pattern (H&E). D, Lower part of the
left lung at the autopsy showing subpleural fibroelastosis [elastica van Gieson (EVG)].
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second biopsy. Although it cannot be denied that CIP
with granulomas and PPFE arose independently,
granulomas were often found at the edge of fibroelas-
tosis, and were associated with the OP pattern
observed in the first biopsy. It is possible that CIP, OP
and granulomas were incorporated into the PPFE pat-
tern. Reddy et al.4 reported a patient with coexistent
PPFE and hypersensitivity pneumonitis in the lower
lobe. Mycobacterial infection, such as that with Myco-
bacterium avium–intracellulare, is another possible
explanation for the histology. However, repeated spu-
tum examinations failed to identify the organisms.
We previously reported a patient with PPFE compli-
cated by M. avium infection.5
It is apparent that there was a close relationship
between the ALI pattern observed in the biopsy and
the PPFE pattern observed in the autopsy in case 4.
Clinical observation proved that there was serial
exacerbation of symptoms and signs in the period
between the biopsy and the autopsy. In addition,
repeated examination by CT demonstrated that
ground-glass opacities at the apex were transformed
into multiple cysts with nodular, reticular and inter-
septal linear opacities. These findings suggest a tem-
poral sequence of ALI followed by the development of
PPFE in the lung-transplanted patient, and were coin-
cident with those observed by Ofek et al.8
We have shown in the present study that there is a
possible temporal continuity in the histological fea-
tures from interstitial inflammation and fibrosis or
ALI to the development of PPFE. These histological
alterations suggest that some inflammatory or lung
injury processes might constitute the first step in the
occurrence and progression of PPFE.
The most important aspect of our speculation is
whether the histology of the autopsies or second biop-
sies of lungs truly reflects the ‘evolutionary process’
of the histology of lung tissues obtained in the first
biopsy. The combination of upper lobe PPFE and
lower lobe UIP4,5 patterns, and the combination of
UIP and NSIP patterns in chronic fibrosing interstitial
pneumonia,2,13 are not rare. As the sampling sites of
the second biopsy or autopsy in our patients included
the upper lobes, where initial lesions had existed, we
think that histology at the second biopsy or autopsy
was the result of the ‘evolutionary process’ of the first
biopsy. Serial imaging findings also supported our
hypothesis.
The second question is whether such a histological
evolution is applicable to all types of PPFE generally.
Our study was performed on the basis of clinical and
histological analyses of only four patients, which is
the major limitation of the present study. As PPFE is
a rare interstitial pneumonia, large-scale studies of
PPFE patients are necessary to confirm our results.
Honeycomb lung is a non-specific end-stage fibrosis
of lung diseases such as IIPs, including UIP.14,15
Interstitial inflammation and fibrosis with or without
granulomas and an ALI pattern as an initial stage
might progress to honeycomb lung as an end-stage
fibrosis of the interstitial lung diseases. Similarly, we
propose subpleural fibroelastosis, considered to be a
histological prototype of PPFE, as an end-stage fibro-
sis of PPFE, idiopathic or secondary, such as trans-
plantation-associated PPFE. As we demonstrated in
the present study that interstitial inflammation and
fibrosis with or without granulomas and ALI were
replaced by subpleural fibroelastosis at various time
intervals, we speculate that these lesions could repre-
sent an initial step in the development of PPFE.
Pleuroparenchymal fibroelastosis may be a healing
reaction. However, PPFE is a distinctive form of
chronic scarring in the lung that differs from the
common scarring seen in IPF.16 PPFE lungs contain
twice as much elastin as IPF lungs.17 Also, a histo-
logical healing reaction in PPFE does not necessarily
mean clinical healing of PPFE. Extensive subpleural
elastosis causes serious clinical problems, such as pro-
gressive restrictive ventilatory impairment associated
with exertional dyspnoea. In that sense, PPFE is a dis-
ease entity.
The histological finding of elastosis is not exclusive
to PPFE. Other IIPs also have increased amounts of
elastic fibres. In the analysis of fibrosing process of
IIPs, little attention has been directed to the elastic
tissue.18,19 Idiopathic PPFE is now a member of the
rare IIPs.2 We have to pay more attention to elastosis
in IIPs, in order to determine any differences in elas-
tosis between idiopathic PPFE and other IIPs, and to
distinguish PPFE as a histological pattern from PPFE
as a disease entity. PPFE as a histological pattern,
which is true of the apical cap, does not require clini-
cal symptoms and signs. On the other hand, PPFE as
a true IIP is a clinical disease with characteristic clin-
ical and physiological findings.
Reddy et al.4 showed underlying conditions in
PPFE: recurrent pulmonary infections, and genetic
and autoimmune mechanisms. However, we were
unable to identify any of the predisposing causes or
diseases described above or a previous history of
malignancy1 (Table 1).
In clinical practice, a diagnosis of PPFE is estab-
lished only at an advanced stage, when subpleural fi-
broelastosis develops. At present, we cannot
distinguish interstitial inflammation and ALI as initial
lesions of PPFE from other inflammatory diseases
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until a typical PPFE pattern emerges. PPFE has been
widely recognized among pulmonologists since the
revised classification of IIPs appeared in 2013.2
Large-scale and long-term accumulation of patients
with PPFE may be needed to elucidate the evolution
of PPFE.
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